{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T10:38:45Z","timestamp":1792579125954,"version":"4.5.0"},"reference-count":14,"publisher":"SAGE Publications","issue":"6","license":[{"start":{"date-parts":[[2013,11,6]],"date-time":"2013-11-06T00:00:00Z","timestamp":1383696000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Feline Medicine and Surgery"],"published-print":{"date-parts":[[2014,6]]},"abstract":"<jats:p>\n                    Feline idiopathic cystitis is a common condition, often resulting in repeated episodes of life-threatening urethral obstruction. Defective urinary bladder glycosaminoglycans have been implicated as a causal factor. In this report, a commercially available glycosaminoglycan product was infused into the urinary bladders of cats with urethral obstruction from idiopathic cystitis to study the effect on repeated obstruction. In this randomized, blind, placebo-controlled clinical trial, the therapeutic protocol was well tolerated with no adverse effects. Whereas no glycosaminoglycan-treated cats (n = 9) developed repeated urethral obstruction during the 7 day follow-up period, 3\/7 placebo-treated cats developed repeated obstructions. Approaching statistical significance (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    = 0.06), these data suggest that further investigation of this new treatment option is warranted.\n                  <\/jats:p>","DOI":"10.1177\/1098612x13510918","type":"journal-article","created":{"date-parts":[[2013,11,6]],"date-time":"2013-11-06T21:36:25Z","timestamp":1383773785000},"page":"504-506","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":18,"title":["Intravesical glycosaminoglycans for obstructive feline idiopathic cystitis: a pilot study"],"prefix":"10.1177","volume":"16","author":[{"given":"Allison M","family":"Bradley","sequence":"first","affiliation":[{"name":"Department of Clinical Sciences, Colorado State University, Fort Collins, CO, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R","family":"Lappin","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Colorado State University, Fort Collins, CO, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2013,11,6]]},"reference":[{"key":"e_1_3_2_2_2","first-page":"15","article-title":"Feline idiopathic lower urinary tract disease: part I. Clinical manifestations","volume":"21","author":"Kalkstein T","year":"1999","unstructured":"Kalkstein T, Kruger J, Osborne C. Feline idiopathic lower urinary tract disease: part I. Clinical manifestations. Compend Contin Educ Prac Vet 1999; 21: 15\u201326.","journal-title":"Compend Contin Educ Prac Vet"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cvsm.2008.09.008"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfms.2011.08.001"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfms.2007.06.007"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1939-1676.2012.00911.x"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagen.2004.02.002"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2008.08028.x"},{"key":"e_1_3_2_9_2","first-page":"328","article-title":"Intravesical glycosaminoglycan replenishment with chondroitin sulphate in chronic forms of cystitis","volume":"58","author":"Nordling J","year":"2008","unstructured":"Nordling J, van Ophoven A. Intravesical glycosaminoglycan replenishment with chondroitin sulphate in chronic forms of cystitis. Drug Res 2008; 58: 328\u2013335.","journal-title":"Drug Res"},{"key":"e_1_3_2_10_2","first-page":"288A","article-title":"Decreased expression of GP-51 glycosaminoglycan in cats afflicted with feline interstitial cystitis","volume":"153","author":"Press S","year":"1995","unstructured":"Press S, Moldwin R, Kushner L, et al. Decreased expression of GP-51 glycosaminoglycan in cats afflicted with feline interstitial cystitis. J Urol 1995; 153: 288A.","journal-title":"J Urol"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.2460\/ajvr.67.4.731"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eursup.2011.06.001"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2010.03.016"},{"key":"e_1_3_2_14_2","first-page":"91","article-title":"Systemic effects of a commercial preparation of chondroitin sulfate, hyaluronic acid and N acetyl-D-glucosamine when administered parenterally to healthy cats","volume":"11","author":"Veir J","year":"2013","unstructured":"Veir J, Webb C, Lappin M. Systemic effects of a commercial preparation of chondroitin sulfate, hyaluronic acid and N acetyl-D-glucosamine when administered parenterally to healthy cats. Intern J Appl Res Vet Med 2013; 11: 91\u201395.","journal-title":"Intern J Appl Res Vet Med"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.2460\/javma.243.4.512"}],"container-title":["Journal of Feline Medicine and Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1098612X13510918","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1098612X13510918","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1098612X13510918","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T09:46:10Z","timestamp":1792575970000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1098612X13510918"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,6]]},"references-count":14,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["10.1177\/1098612X13510918"],"URL":"https:\/\/doi.org\/10.1177\/1098612x13510918","relation":{},"ISSN":["1098-612X","1532-2750"],"issn-type":[{"value":"1098-612X","type":"print"},{"value":"1532-2750","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,6]]}}}